Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.70
Bid: 32.00
Ask: 33.40
Change: -0.40 (-1.21%)
Spread: 1.40 (4.375%)
Open: 33.10
High: 33.20
Low: 32.70
Prev. Close: 33.10
MERC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison Investment Research Limited: Mercia Asset Management (MERC): The UK's top regional investor

3 Mar 2021 07:00

Edison Investment Research Limited Edison Investment Research Limited: Mercia Asset Management (MERC): The UK's top regional investor 03-March-2021 / 07:00 GMT/BST


 

London, UK, 3 March 2021

 

Mercia Asset Management (MERC): The UK's top regional investor

The £30.7m cash exit from Oxgene underlines management's success in building a sustainably profitable specialist asset manager, delivering high levels of contracted revenue and providing a filtered pipeline of opportunities for Mercia's direct investment portfolio. Based on progress to date, we believe Mercia will achieve its three-year strategic plan ahead of time (grow operating profitability, expand assets under management (AUM) to £1bn and 'evergreen' the balance sheet by end FY22). By the end of H121, AUM had risen to £872m (15% from FY22 target), with fee-earning funds under management (FUM) of £722m. Despite progress, Mercia's shares continue to trade at a material 21% discount to net assets (0.79x) or a 30-35% discount when we include the third-party funds business (worth 4.9p at 3% of FUM). This is a substantial discount to its peers.

 

Although profitable and dividend paying, with a mature, evergreen balance sheet, and scaling AUM, Mercia still trades at a 21% discount to its H121 NAV (34.1p per share) and a significant discount to its peers. Together with its fund management arm (5-8p per share), the overall valuation rises to 39-42p per share, implying a discount of closer to 31-36%. Catalysts for a re-rating include further scaling of the business, continuing revenue/earnings growth, commercialisation of the direct investment portfolio and/or successful exits.  

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Richard Williamson +44 (0)20 3077 5700 tech@edisongroup.com

Rob Murphy +44 (0)20 3077 5700 tech@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group-/

Twitter  www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1172526 03-March-2021 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
5th Jul 20227:00 amRNSPreliminary Results
27th Jun 20227:00 amRNSInvestor Presentation
23rd May 20227:00 amRNSNotice of Results
16th May 20227:00 amRNSPublication of ‘The Insight’ Newsletter
12th May 20227:00 amRNSMercia's EIS Funds raise c.£20million
26th Apr 202210:27 amRNSTR-1: Notification of major holdings
11th Apr 20227:00 amRNSUpdate on proceeds from sale of Faradion
1st Apr 202211:10 amRNSTR-1: Notification of major holdings
29th Mar 20227:00 amRNSnDreams receives significant new investment
10th Mar 20227:06 amRNSMercia’s Northern VCTs raise £40.0million
28th Feb 20227:00 amRNSFurther direct investment into MIP Diagnostics
18th Feb 20229:49 amRNSTR-1: Notification of major holdings
5th Jan 202212:36 pmRNSDirector/PDMR Dealings
5th Jan 20227:00 amRNSCompletion of the sale of Faradion
31st Dec 20217:00 amRNSSale of Faradion Limited
22nd Dec 20217:00 amRNSFurther direct investment into Intechnica Group
7th Dec 20217:00 amRNSInterim Results
2nd Dec 20217:00 amRNSSoccer Manager secures significant new licences
25th Nov 20217:00 amRNSNVT performance fee entitlement and trading update
22nd Nov 20217:00 amRNSInvestor Presentation
2nd Nov 20217:00 amRNSMercia announces a new direct investment
27th Oct 20217:00 amRNSNotice of Interim Results
26th Oct 20217:00 amRNSMercia announces new direct investment
21st Oct 20217:00 amRNSPublication of newsletter
14th Sep 202110:21 amRNSResult of AGM
14th Sep 20217:00 amRNSAGM Statement
3rd Sep 20217:00 amRNSInvestment into Locate Bio
10th Aug 20217:00 amRNSMercia accredited to deliver Recovery Loan Scheme
4th Aug 20217:00 amRNSnDreams appoints new Non-executive Chair
30th Jul 20217:00 amRNSPublication of Annual Report and Notice of AGM
15th Jul 20217:00 amRNSNotification of Major Holdings
12th Jul 20217:00 amRNSGrant of Options
8th Jul 20212:56 pmRNSDirector/PDMR Dealings
6th Jul 20217:00 amRNSPreliminary results
24th Jun 20217:00 amRNSInvestor Presentation
23rd Jun 20213:16 pmRNSPerformance fee entitlement and trading update
10th May 20217:00 amRNSPublication of "The Insight" Newsletter
15th Apr 20217:00 amRNSNotice of Results
12th Apr 20217:00 amRNSVirtual shareholder event
6th Apr 20212:37 pmRNSMyHealthChecked plc signs major contract
5th Mar 202112:46 pmRNSNotification of Major Holdings
4th Mar 20214:09 pmRNSDirector/PDMR Dealings
3rd Mar 20217:00 amEQSEdison Investment Research Limited: Mercia Asset Management (MERC): The UK's top regional investor
1st Mar 20213:31 pmRNSTrading Update
1st Mar 20213:27 pmRNSSale of Oxford Genetics Limited
23rd Feb 20217:00 amRNSSoccer Manager receives £3.0million investment
2nd Feb 20217:00 amRNSSoftware and eCommerce portfolio update
29th Jan 20217:00 amRNSChange of Auditor
8th Dec 20207:00 amRNSQuarterly newsletter
2nd Dec 20207:00 amRNSPerformance fee entitlement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.